Dual role of oxidized LDL on the NF-KappaB signaling, pathway

Free Radical Research

Volumn 38, Issue 6, 2004, Pages 541-551

  Robbesyn, Fanny ^a   Salvayre, Robert ^a   Negre Salvayre, Anne ^a  

^a CHU RANGUEIL   (France)

Author keywords

Atherosclerosis; Inflammation; NF B; Oxidized LDL; Reactive oxygen species

Indexed keywords

CELL ADHESION MOLECULE; CHEMOATTRACTANT; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR; THROMBOPLASTIN; TRANSCRIPTION FACTOR;

AGE; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); DISEASE COURSE; DOWN REGULATION; ENDOTHELIUM; FOAM CELL; GENE EXPRESSION; HUMAN; IMMUNOREGULATION; INFLAMMATION; ISCHEMIC HEART DISEASE; LEUKOCYTE ACTIVATION; LIPID OXIDATION; MONONUCLEAR CELL; OXIDATION REDUCTION REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REVIEW; SIGNAL TRANSDUCTION; THROMBOSIS; UPREGULATION;

ANIMALS; ARTERIOSCLEROSIS; CELL SURVIVAL; HUMANS; LIPOPROTEINS, LDL; MICE; MODELS, BIOLOGICAL; NF-KAPPA B; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 2542533762     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760410001665244     Document Type: Review

References (120)

1. Stary, H.C. (1990) "The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life", Eur. Heart J. 11, 3-19.
2. Lusis, A.J. (2000) "Atherosclerosis", Nature 407, 233-241.
3. Ross, R. (1993) "The pathogenesis of atherosclerosis: a perspective for the 1990s", Nature 362, 801-809.
4. Witztum, J.L. and Steinberg, D. (1991) "Role of oxidized low density lipoprotein in atherogenesis", J. Clin. Investig. 88, 1785-1792.
5. Napoli, C., de Nigris, F. and Palinski, W. (2001) "Multiple role of reactive oxygen species in the arterial wall", J. Cell. Biochem. 82, 674-682.
6. Hajjar, D.P. and Haberland, M.E. (1997) "Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs", J. Biol. Chem. 272, 22975-22978.
7. Salvayre, R., Auge, N., Benoist, H. and Negre-Salvayre, A. (2002) "Oxidized low-density lipoprotein-induced apoptosis", Biochim. Biophys. Acta 1585, 213-221.
8. Berliner, J.A., Navab, M., Fogelman, A.M., Frank, J.S., Demer, L.L., Edwards, P.A., Watson, A.D. and Lusis, A.J. (1995) "Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics", Circulation 91, 2488-2496.
9. Brand, K., Eisele, T., Kreusel, U., Page, M., Page, S., Haas, M., Gerling, A., Kaltschmidt, C., Neumann, F.J., Mackman, N., Baeurele, P.A., Walli, A.K. and Neumeier, D. (1997) "Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein", Arterioscler. Thromb. Vasc. Biol. 17, 1901-1909.
10. Ghosh, S. and Karin, M. (2002) "Missing pieces in the NF-kappaB puzzle", Cell 109, S81-S96.
11. May, M.J. and Ghosh, S. (1998) "Signal transduction through NF-kappa B", Immunol. Today 19, 80-88.
12. Barnes, P.J. and Karin, M. (1997) "Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases", N. Engl. J. Med. 336, 1066-1071.
13. Valen, G., Yan, Z.Q. and Hansson, G.K. (2001) "Nuclear factor kappa-B and the heart", J. Am. Coll. Cardiol. 38, 307-314.
14. Ross, J.S., Stagliano, N.E., Donovan, M.J., Breitbart, R.E. and Ginsburg, G.S. (2001) "Atherosclerosis and cancer: common molecular pathways of disease development and progression", Ann. N.Y. Acad. Sci. 947, 271-292, discussion 292, 273.
15. Karin, M. (1999) "The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation", J. Biol. Chem. 274, 27339-27342.
16. Zandi, E. and Karin, M. (1999) "Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex", Mol. Cell. Biol. 19, 4547-4551.
17. Karin, M. and Delhase, M. (2000) "The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling", Semin. Immunol. 12, 85-98.
18. Sanz, L., Sanchez, P., Lallena, M.J., Diaz-Meco, M.T. and Moscat, J. (1999) "The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation", EMBO J. 18, 3044-3053.
19. Ozes, O.N., Mayo, L.D., Gustin, J.A., Pfeffer, S.R., Pfeffer, L.M. and Donner, D.B. (1999) "NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase", Nature 401, 82-85.
20. Peters, R.T. and Maniatis, T. (2001) "A new family of IKK-related kinases may function as I kappa B kinase kinases", Biochim. Biophys. Acta 1471, M57-M62.
21. Bowie, A. and O'Neill, L.A. (2000) "Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries", Biochem. Pharmacol. 59, 13-23.
22. Kamata, H., Manabe, T., Oka, S., Kamata, K. and Hirata, H. (2002) "Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops", FEBS Lett. 519, 231-237.
23. Schoonbroodt, S. and Piette, J. (2000) "Oxidative stress interference with the nuclear factor-kappa B activation pathways", Biochem. Pharmacol. 60, 1075-1083.
24. Janssen-Heininger, Y.M., Poynter, M.E. and Baeuerle, P.A. (2000) "Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB", Free Radic. Biol. Med. 28, 1317-1327.
25. Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P.A. and Neumeier, D. (1996) "Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion", J. Clin. Investig. 97, 1715-1722.
26. Hajra, L., Evans, A.I., Chen, M., Hyduk, S.J., Collins, T. and Cybulsky, M.I. (2000) "The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation", Proc. Nalt Acad. Sci. USA 97, 9052-9057.
27. Ritchie, M.E. (1998) "Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris", Circulation 98, 1707-1713.
28. Wilson, S.H., Best, P.J., Edwards, W.D., Holmes, D.R., Jr., Carlson, P.J., Celermajer, D.S. and Lerman, A. (2002) "Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris", Atherosclerosis 160, 147-153.
29. Liao, F., Berliner, J.A., Mehrabian, M., Navab, M., Demer, L.L., Lusis, A.J. and Fogelman, A.M. (1991) "Minimally modified low density lipoprotein is biologically active in vivo in mice", J. Clin. Investig. 87, 2253-2257.
30. Liao, F., Andalibi, A., deBeer, F.C., Fogelman, A.M. and Lusis, A.J. (1993) "Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice", J. Clin. Investig. 91, 2572-2579.
31. Wilson, S.H., Caplice, N.M., Simari, R.D., Holmes, D.R., Jr., Carlson, P.J. and Lerman, A. (2000) "Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia", Atherosclerosis 148, 23-30.
32. Calara, E, Dimayuga, P., Niemann, A., Thyberg, J., Diczfalusy, U., Witztum, J.L., Palinski, W., Shah, P.K., Cercek, B., Nilsson, J. and Regnstrom, J. (1998) "An animal model to study local oxidation of LDL and its biological effects in the arterial wall", Arterioscler. Thromb. Vasc. Biol. 18, 884-893.
33. Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S. and Baltimore, D. (1995) "Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B", Nature 376, 167-170.
34. Natarajan, R., Reddy, M.A., Malik, K.U., Fatima, S. and Khan, B.V. (2001) "Signaling mechanisms of nuclear factor-kappab-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells", Arterioseler. Thromb. Vasc. Biol. 21, 1408-1413.
35. Subbanagounder, G., Leitinger, N., Schwenke, D.C., Wong, J.W., Lee, H., Rizza, C., Watson, A.D., Faull, K.F., Fogelman, A.M. and Berliner, J.A. (2000) "Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position", Arterioscler. Thromb. Vasc. Biol. 20, 2248-2254.
36. Subbanagounder, G., Watson, A.D. and Berliner, J.A. (2000) "Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities", Free Radic. Biol. Med. 28, 1751-1761.
37. Sugiyama, S., Kugiyama, K., Ogata, N., Doi, H., Ota, Y., Ohgushi, M., Matsumura, T., Oka, H. and Yasue, H. (1998) "Biphasic regulation of transcription factor nuclear factor-kappaB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway", Arterioscler. Thromb. Vasc. Biol. 18, 568-576.
38. Kume, N., Cybulsky, M.I. and Gimbrone, M.A., Jr. (1992) "Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells", J. Clin. Investig. 90, 1138-1144.
39. Takahara, N., Kashiwagi, A., Maegawa, H. and Shigeta, Y. (1996) "Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells", Metabolism 45, 559-564.
40. Zhu, Y, Lin, J.H., Liao, H.L., Verna, L. and Stemerman, M.B. (1997) "Activation of ICAM-1 promoter by lysophosphatidylcholine: possible involvement of protein tyrosine kinases", Biochim. Biophys. Acta 1345, 93-98.
41. Brown, A.J. and Jessup, W. (1999) "Oxysterols and atherosclerosis", Atherosclerosis 142, 1-28.
42. Lizard, G., Gueldry S., Sordet, O., Monier, S., Athias, A., Miguet, C., Bessede, G., Lemaire, S., Solary, E. and Gambert, P. (1998) "Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production", FASEB J. 12, 1651-1663.
43. Alberti, S., Steffensen, K.R. and Gustafsson, J.A. (2000) "Structural characterisation of the mouse nuclear oxysterol receptor genes LXRalpha and LXRbeta", Gene 243, 93-103.
44. Leonarduzzi, G., Sottero, B. and Poli, G. (2002) "Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects (review)", J. Nutr. Biochem. 13, 700-710.
45. Leonarduzzi, G., Arkan, M.C., Basaga, H., Chiarpotto, E., Sevanian, A. and Poli, G. (2000) "Lipid oxidation products in cell signaling", Free Radic. Biol. Med. 28, 1370-1378.
46. Robbesyn, F., Garcia, V., Auge, N., Vieira, O., Frisach, M.F., Salvayre, R. and Negre-Salvayre, A. (2003) "HDL counter-balance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells", FASEB J. 17, 543-745.
47. Parola, M., Robino, G., Marra, E, Pinzani, M., Bellomo, G., Leonarduzzi, G., Chiarugi, P., Camandola, S., Poli, G., Waeg, G., Gentilini, P. and Dianzani, M.U. (1998) "HNE interacts directly with JNK isoforms in human hepatic stellate cells", J. Clin. Investig. 102, 1942-1950.
48. Camandola, S., Scavazza, A., Leonarduzzi, G., Biasi, E, Chiarpotto, E., Azzi, A. and Poli, G. (1997) "Biogenic 4-hydroxy-2-nonenal activates transcription factor AP-1 but not NF-kappa B in cells of the macrophage lineage", Biofactors 6, 173-179.
49. Page, S., Fischer, C., Baumgartner, B., Haas, M., Kreusel, U., Loidl, G., Hayn, M., Ziegler-Heitbrock, H.W., Neumeier, D. and Brand, K. (1999) "4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis", J. Biol. Chem. 274, 11611-11618.
50. Maziere, C., Auclair, M., Djavaheri-Mergny, M., Packer, L. and Maziere, J.C. (1996) "Oxidized low density lipoprotein induces activation of the transcription factor NF kappa B in fibroblasts, endothelial and smooth muscle cells", Biochem. Mol. Biol. Int. 39, 1201-1207.
51. Auge, N., Garcia, V, Maupas-Schwalm, E, Levade, T., Salvayre, R. and Negre-Salvayre, A. (2002) "Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways", Arterioscler. Thromb. Vasc. Biol. 22, 1990-1995.
52. Romashkova, J.A. and Makarov, S.S. (1999) "NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling", Nature 401, 86-90.
53. Madrid, L.V., Mayo, M.W., Reuther, J.Y. and Baldwin, A.S., Jr. (2001) "Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38", J. Biol. Chem. 276, 18934-18940.
54. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P.G., Coso, O.A., Gutkind, S. and Spiegel, S. (1996) "Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate", Nature 381, 800-803.
55. Xia, P., Wang, L., Gamble, J.R. and Vadas, M.A. (1999) "Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells", J. Biol. Chem. 274, 34499-34505.
56. Xia, P., Gamble, J.R., Rye, K.A., Wang, L., Hii, C.S., Cockerill, P., Khew-Goodall, Y., Bert, A.G., Barter, P.J. and Vadas, M.A. (1998) "Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway", Proc. Natl Acad. Sci. USA 95, 14196-14201.
57. Shatrov, V.A., Lehmann, V. and Chouaib, S. (1997) "Sphingosine-1-phosphate mobilizes intracellular calcium and activates transcription factor NF-kappa B in U937 cells", Biochem. Biophys. Res. Commun. 234, 121-124.
58. Auge, N., Nikolova-Karakashian, M., Carpentier, S., Parthasarathy, S., Negre-Salvayre, A., Salvayre, R., Merrill, A.H., Jr. and Levade, T. (1999) "Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase", J. Biol. Chem. 274, 21533-21538.
59. Cominacini, L., Pasini, A.F., Garbin, U., Davoli, A., Tosetti, M.L., Campagnola, M., Rigoni, A., Pastorino, A.M., Lo Cascio, V. and Sawamura, T. (2000) "Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species", J. Biol. Chem. 275, 12633-12638.
60. Cominacini, L., Rigoni, A., Pasini, A.F., Garbin, U., Davoli, A., Campagnola, M., Pastorino, A.M., Lo Cascio, V and Sawamura, T. (2001) "The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide", J. Biol. Chem. 276, 13750-13755.
61. Shimamura, A., Ballif, B.A., Richards, S.A. and Blenis, J. (2000) "Rsk1 mediates a MEK-MAP kinase cell survival signal", Curr. Biol. 10, 127-135.
62. Frodin, M. and Gammeltoft, S. (1999) "Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction", Mol. Cell. Endocrinol. 151, 65-77.
63. Auge, N., Pieraggi, M.T., Thiers, J.C., Negre-Salvayre, A. and Salvayre, R. (1995) "Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells", Biochem. J. 309, 1015-1020.
64. Ares, M.P., Kallin, B., Eriksson, P. and Nilsson, J. (1995) "Oxidized LDL induces transcription factor activator protein-1 but inhibits activation of nuclear factor-kappa B in human vascular smooth muscle cells", Arterioscler Thromb. Vasc. Biol. 15(10), 1584-1590.
65. Ohlsson, B.G., Englund, M.C., Karlsson, A.L., Knutsen, E., Erixon, C., Skribeck, H., Liu, Y., Bondjers, G. and Wiklund, O. (1996) "Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages", J. Clin. Investig. 98, 78-89.
66. Hourton, D., Stengel, D., Chapman, M.J. and Ninio, E. (2001) "Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: implications for LPS-induced nuclear factor-kappaB binding activity", Eur. J. Biochem. 268, 4489-4496.
67. Bochkov, V.N. and Leitinger, N. (2003) "Anti-inflammatory properties of lipid oxidation products", J. Mol. Med. 81, 613-626.
68. Caspar-Bauguil, S., Tkaczuk, J., Haure, M.J., Durand, M., Alcouffe, J., Thomsen, M., Salvayre, R. and Benoist, H. (1999) " Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes", Biochem. J. 337, 269-274.
69. Engelmann, B., Zieseniss, S., Brand, K., Page, S., Lentschat, A., Ulmer, A.J. and Gerlach, E. (1999) "Tissue factor expression of human monocytes is suppressed by lysophosphatidylcholine", Arterioscler. Thromb. Vasc. Biol. 19, 47-53.
70. Eligini, S., Brambilla, M., Banfi, C., Camera, M., Sironi, L., Barbieri, S.S., Auwerx, J., Tremoli, E. and Colli, S. (2002) "Oxidized phospholipids inhibit cyclooxygenase-2 in human macrophages via nuclear factor-kappaB/IkappaB-and ERK2-dependent mechanisms", Cardiovasc. Res. 55, 406415.
71. Ji, C., Kozak, K.R. and Marnett, L.J. (2001) "IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal", J. Biol. Chem. 276, 18223-18228.
72. Vieira, O., Escargueil-Blanc, I., Jurgens, G., Borner, C., Almeida, L., Salvayre, R. and Negre-Salvayre, A. (2000) "Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis", FASEB J. 14, 532-542.
73. Okada, K., Wangpoengtrakul, C., Osawa, T., Toyokuni, S., Tanaka, K. and Uchida, K. (1999) "4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules", J. Biol. Chem. 274, 23787-23793.
74. Uchida, K. (2003) "4-Hydroxy-2-nonenal: a product and mediator of oxidative stress", Prog. Lipid Res. 42, 318-343.
75. Nagy, L., Tontonoz, P., Alvarez, J.G., Chen, H. and Evans, R.M. (1998) "Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma", Cell 93, 229-240.
76. Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J. and Glass, C.K. (1998) "The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation", Nature 391, 79-82.
77. Duval, C., Chinetti, G., Trottein, F., Fruchart, J. and Staels, B. (2002) "The role of PPARs in atherosclerosis", Trends Mol. Med. 8, 422-430.
78. Mallat, Z. and Tedgui, A. (2000) "Apoptosis in the vasculature: mechanisms and functional importance", Br. J. Pharmacol. 130, 947-962.
79. Delerive, P, Gervois, P., Fruchart, J.C. and Staels, B. (2000) "Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators", J. Biol. Chem. 275, 36703-36707.
80. Klucis, E., Crane, D. and Masters, C. (1984) "Sequential alterations in the micro-localization of catalase in mouse liver after treatment with hypolipidemic drugs", Mol. Cell. Biochem. 65, 73-82.
81. Edwards, P.A., Kennedy, M.A. and Mak, P.A. (2002) "LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis", Vascul. Pharmacol. 38, 249-256.
82. Joseph, S.B., Castrillo, A., Laffitte, B.A., Mangelsdorf, D.J. and Tontonoz, P. (2003) "Reciprocal regulation of inflammation and lipid metabolism by liver X receptors", Nat. Med. 9, 213-219.
83. Castrillo, A., Joseph, S.B., Marathe, C., Mangelsdorf, D.J. and Tontonoz, P. (2003) "Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages", J. Biol. Chem. 278, 10443-10449.
84. Englund, M.C., Karlsson, A.L., Wiklund, O., Bondjers, G. and Ohlsson, B.G. (2001) "25-hydroxycholesterol induces lipopolysaccharide-tolerance and decreases a lipopolysaccharide-induced TNF-alpha secretion in macrophages", Atherosclerosis 158, 61-71.
85. Suske, G. (1999) "The Sp-family of transcription factors", Gene 238, 291-300.
86. Karin, M. and Lin, A. (2002) "NF-kappaB at the crossroads of life and death", Nat. Immunol. 3, 221-227.
87. De Martin, R., Hoeth, M., Hofer-Warbinek, R. and Schmid, J.A. (2000) "The transcription factor NF-kappa B and the regulation of vascular cell function", Arterioscler. Thromb. Vasc. Biol. 20, 83-88.
88. Nishio, E., Kanda, Y., Kuroki, Y. and Watanabe, Y. (2000) "The potentiation of oxLDL induced apoptosis by inhibition of NF-kappaB", Life Sci. 67, 1983-1992.
89. Zen, K., Karsan, A., Stempien-Otero, A., Yee, E., Tupper, J., Li, X., Eunson, T., Kay, M.A., Wilson, C.B., Winn, R.K. and Harlan, J.M. (1999) "NF-kappaB activation is required for human endothelial survival during exposure to tumor necrosis factor-alpha but not to interleukin-1beta or lipopolysaccharide", J. Biol. Chem. 274, 28808-28815.
90. Liu, H., Lo, C.R. and Czaja, M.J. (2002) "NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun", Hepatology 35, 772-778.
91. Li, D. and Mehta, J.L. (2000) "Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors", Arterioscler. Thromb. Vasc. Biol. 20, 1116-1122.
92. Aoyama, T., Sawamura, T., Furutani, Y., Matsuoka, R., Yoshida, M.C., Fujiwara, H. and Masaki, T. (1999) "Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene", Biochem. J. 339, 177-184.
93. Li, D., Saldeen, T., Romeo, F. and Mehta, J.L. (2000) "Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB", Circulation 102, 1970-1976.
94. Nickenig, G. (2002) "Central role of the AT(1)-receptor in atherosclerosis", J. Hum. Hypertens 16(Suppl. 3), S26-S33.
95. Bascands, J.L., Girolami, J.P., Troly, M., Escargueil-Blanc, I., Nazzal, D., Salvayre, R. and Blaes, N. (2001) "Angiotensin II induces phenotype-dependent apoptosis in vascular smooth muscle cells", Hypertension 38, 1294-1299.
96. Hsu, S.C., Gavrilin, M.A., Lee, H.H., Wu, C.C., Han, S.H. and Lai, M.Z. (1999) "NF-kappa B-dependent Fas ligand expression", Eur. J. Immunol. 29, 2948-2956.
97. Chan, H., Bartos, D.P. and Owen-Schaub, L.B. (1999) "Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment", Mol. Cell. Biol. 19, 2098-2108.
98. Qin, Z.H., Chen, R.W., Wang, Y., Nakai, M., Chuang, D.M. and Chase, T.N. (1999) "Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum", J. Neurosci. 19, 4023-4033.
99. Ross, R. (1999) "Atherosclerosis - an inflammatory disease", N. Engl. J. Med. 340, 115-126.
100. Libby, P. (2002) "Inflammation in atherosclerosis", Nature 420, 868-874.
101. Berliner, JA., Territo, M.C., Sevanian, A., Ramin, S., Kim, J.A., Bamshad, B., Esterson, M. and Fogelman, A.M. (1990) "Minimally modified low density lipoprotein stimulates monocyte endothelial interactions", J. Clin. Investig. 85, 1260-1266.
102. Rajavashisth, T.B., Andalibi, A., Territo, M.C., Berliner, J.A., Navab, M., Fogelman, A.M. and Lusis, A.J. (1990) "Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins", Nature 344, 254-257.
103. De Caterina, R., Libby, P., Peng, H.B., Thannickal, V.J., Rajavashisth, T.B., Gimbrone, Jr., M.A., Shin, W.S. and Liao, J.K. (1995) "Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines", J. Clin. Investig. 96, 60-68.
104. Peng, H.B., Spiecker, M. and Liao, J.K. (1998) "Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation", J. Immunol. 161, 1970-1976.
105. Peng, H.B., Libby, P. and Liao, J.K. (1995) "Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B", J. Biol. Chem. 270, 14214-14219.
106. Matthews, J.R., Botting, C.H., Panico, M., Morris, H.R. and Hay, R.T. (1996) "Inhibition of NF-kappaB DNA binding by nitric oxide", Nucleic Acids Res. 24, 2236-2242.
107. Yang, X., Cai, B., Sciacca, R.R. and Cannon, P.J. (1994) "Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins", Circ. Res. 74, 318-328.
108. Hattori, Y., Hattori, S. and Kasai, K. (2001) "4-Hydroxynonenal prevents NO production in vascular smooth muscle cells by inhibiting nuclear factor-kappaB-dependent transcriptional activation of inducible NO synthase", Arterioscler. Thromb. Vasc. Biol. 21, 1179-1183.
109. Huang, A., Li, C., Kao, R.L. and Stone, W.L. (1999) "Lipid hydroperoxides inhibit nitric oxide production in RAW264.7 macrophages", Free Radic. Biol. Med. 26, 526-537.
110. Carmeliet, P. and Collen, D. (1998) "Tissue factor", Int. J. Biochem. Cell. Biol. 30, 661-667.
111. Tremoli, E., Camera, M., Toschi, V. and Colli, S. (1999) "Tissue factor in atherosclerosis", Atherosclerosis 144, 273-283.
112. Mackman, N. (1995) "Regulation of the tissue factor gene", FASEB J. 9, 883-889.
113. Brand, K., Banka, C.L., Mackman, N., Terkeltaub, R.A., Fan, S.T. and Curtiss, L.K. (1994) "Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes", Arterioscler. Thromb. 14, 790-797.
114. Ardissino, D., Merlini, P.A., Arlens, R., Coppola, R., Bramucci, E., Lucreziotti, S., Repetto, A., Fetiveau, R. and Mannucci, P.M. (2000) "Tissue factor in human coronary atherosclerotic plaques", Clin. Chim. Acta 291, 235-240.
115. Lewis, J.C., Bennett-Cain, A.L., DeMars, C.S., Doellgast, G.J., Grant, K.W., Jones, N.L. and Gupta, M. (1995) "Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein. Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface", Am. J. Pathol. 147, 1029-1040.
116. Drake, T.A., Hannani, K., Fei, H.H., Lavi, S. and Berliner, J.A. (1991) "Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells", Am. J. Pathol. 138, 601-607.
117. Cui, M.Z., Penn, M.S. and Chisolm, G.M. (1999) "Native and oxidized low density lipoprotein induction of tissue factor gene expression in smooth muscle cells is mediated by both Egr-1 and Sp1" , J. Biol. Chem. 274, 32795-32802.
118. Bochkov, V.N., Mechtcheriakova, D., Lucerna, M., Huber, J., Malli, R., Graier, W.F., Hofer, E., Binder, B.R. and Leitinger, N. (2002) "Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT", Blood 99, 199-206.
119. Horie, S., Hiraishi, S., Hirata, Y., Kazama, M. and Matsuda, J. (2000) "Oxidized low-density lipoprotein impairs the anticoagulant function of tissue-factor-pathway, inhibitor through oxidative modification by its high association and accelerated degradation in cultured human endothelial cells", Biochem. J. 352, 277-285.
120. Horie, S., Hiraishi, S., Hamuro, T., Kamikubo, Y. and Matsuda, J. (2002) "Oxidized low-density lipoprotein associates strongly with carboxy-terminal domain of tissue factor pathway inhibitor and reduces the catalytic activity of the protein", Thromb. Haemost. 87, 80-85.